National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

This is VAERS ID 1347946

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 7/9/2021

VAERS ID: 1347946
VAERS Form:2
Age:85.0
Sex:Female
Location:Foreign
Vaccinated:2021-03-15
Onset:2021-03-30
Submitted:0000-00-00
Entered:2021-05-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH UNKNOWN / 2 - / OT

Administered by: Other      Purchased by: ??
Symptoms: Cerebral haemorrhage, Platelet count, Thrombocytopenia, SARS-CoV-2 test

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:2021-04-25
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FUROSEMID; SODIUM PICOSULFATE; CANDESARTAN; BISOPROLOL; APIXABAN; AMLODIPINE
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Arrhythmia absoluta; Arterial hypertension; Chronic renal insufficiency; Heart failure; Rectal carcinoma
Allergies:
Diagnostic Lab Data: Test Date: 20210330; Test Name: thrombocytopenia; Result Unstructured Data: Test Result:2; Comments: /nl; Test Date: 20210325; Test Name: SARS-CoV 2 test; Test Result: Negative
CDC 'Split Type': DEPFIZER INC2021574601

Write-up: suspicion on intracerebral bleeding; Thrombocytopenia until 2/nl; This is a spontaneous report from a non-contactable physician. A 85-year-old female patient received second dose of bnt162b2 (COMIRNATY) intramuscular on 15Mar2021 (Batch/Lot Number: Unknown) as 2nd dose, single for covid-19 immunisation. Medical history included arterial hypertension, state after rectum carcinoma from 2008, heart failure from 2008, chronic renal insufficiency from 2008, absolute arrhythmia from 2008. Historical vaccine included first dose of bnt162b2 (COMIRNATY) intramuscular on 16Feb2021 (Batch/Lot Number: Unknown) for covid-19 immunisation. Concomitant medications included furosemide (FUROSEMID); sodium picosulfate; candesartan; bisoprolol; apixaban; amlodipine; all taken for an unspecified indication, start and stop date were not reported. The patient experienced thrombocytopenia until 2/nl on 30Mar2021. Event seriousness criteria was death. Treatment received for the adverse event included imungglobulines and romiplostim. The lab test included sars-cov-2 test: negative on 25Mar2021. The patient died on 25Apr2021. Cause of death was reported as suspicion on intracerebral bleeding. An autopsy was not performed. No follow-up attempts are possible, information about lot/batch number cannot be obtained.; Sender''s Comments: Based on chronological connection to the vaccine, a causal relationship between events thrombocytopenia and intracerebral bleeding and BNT162B2 (COMIRNATY) vaccine cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: suspicion on intracerebral bleeding; Thrombocytopenia until 2/nl

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=1347946&WAYBACKHISTORY=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166